Journal of the American Chemical Society
COMMUNICATION
deiodination in the presence of ID-3, which may account for the
insensitivity of this enzyme toward IAA.
(8) (a) K €o hrle, J.; Hesch, R. D. Horm. Metab. Res., Suppl. Ser. 1984,
4, 42–55. (b) Berry, M. J. J. Biol. Chem. 1992, 267, 18055–18059.
1
(9) Kuiper, G. G. J. M.; Klootwijk, W.; Visser, T. J. Endocrinology
In conclusion, we have shown that naphthyl-based com-
pounds having two selenol groups are remarkably more efficient
mimics of iodothyronine deiodinase than ones having two thiol
groups or a thiolꢀselenol pair. An increase in the reactivity of the
selenol by introducing a basic amino group or increasing the pH
of the reaction medium does not change the regioselectivity of
deiodination. The cooperative effects of nucleophilic thiol and
selenol groups play an important role in the inner-ring deiodina-
tion of thyroxine. This study suggests that an increase in the
nucleophilic reactivity of the conserved Cys residue at the active
site of ID-3 is very important for effective deiodination, as an
activated Cys may cooperate well with the Sec residue in
polarizing the CꢀI bonds in T4 and T3. The insensitivity of
ID-3 toward the ID-1 inhibitor iodoacetic acid (IAA) can be
ascribed to the facile inactivation of IAA by ID-3-mediated
deiodination.
2
003, 144, 2505–2513.
(10) It has been shown that ∼50% of the DTT molecules undergo
monodeprotonation at pH 9.0. For details, see: Mottley, C.; Mason, R. P.
J. Biol. Chem. 2001, 276, 42677–42683.
(11) Nucleophilic attack of a thiol or selenol at the positively
charged iodine is consistent with the mechanism previously proposed
by Goto et al.
(12) (a) Chave, K. J.; Galivan, J.; Ryan, T. J. Biochem. J. 1999,
343, 551–555. (b) Bruno, M. A.; Pardo, M. F.; Caffini, N. O.; L ꢀo pez,
L. M. I. J. Protein Chem. 2003, 22, 127–134.
6
(
13) Mauri, P.; Benazzi, L.; Floh ꢀe , L.; Maiorino, M.; Pietta, P. G.;
Pilawa, S.; Roveri, A.; Ursini, F. Biol. Chem. 2003, 384, 575–588.
14) Zhong, L.; Arn ꢀe r, E. S. J.; Holmgren, A. Proc. Natl. Acad. Sci. U.S.A.
000, 97, 5854–5859.
15) The deiodination of IAA could be conveniently followed by H
(
2
1
(
NMR spectroscopy. When IAA was added to compound 5, rapid and
quantitative conversion of IAA to acetic acid was observed. Similarly,
iodoacetamide, bromoacetic acid, and bromoacetamide were dehaloge-
nated by 5, although the debromination was found to be much slower
than the deiodination.
’
ASSOCIATED CONTENT
S
Supporting Information. Details of experimental proce-
b
dures, chemical syntheses, and assay conditions. This material is
available free of charge via the Internet at http://pubs.acs.org.
’
AUTHOR INFORMATION
Corresponding Author
’
ACKNOWLEDGMENT
This study was supported by the Department of Science and
Technology (DST), New Delhi. G.M. acknowledges the DST for
the award of a Swarnajayanti Fellowship, and D.M. thanks the
Indian Institute of Science for a fellowship. We thank Prof. Josef
K €o hrle for helpful discussions.
’
REFERENCES
(1) (a) Behne, D.; Kyriakopoulos, A.; Meinhold, H.; K €o hrle,
J. Biochem. Biophys. Res. Commun. 1990, 173, 1143–1149. (b) Leonard,
J. L.; Visser, T. J. In Thyroid Hormone Metabolism; Hennemann, G., Ed.;
Marcel Dekker: New York, 1986; p 189. (c) Berry, M. J.; Banu, L.;
Larsen, P. R. Nature 1991, 349, 438–440. (d) Larsen, P. R.; Berry, M. J.
Annu. Rev. Nutr. 1995, 15, 323. (e) Leonard, J. L.; K €o hrle, J. In The
Thyroid; Braverman, L. E., Utiger, R. D., Eds.; Lippincott-Raven:
Philadelphia, 1996; p 144. (f) St. Germain, D. L.; Galton, V. A. Thyroid
1
997, 7, 655.
2) (a) Bianco, A. C.; Salvatore, D.; Gereben, B.; Berry, M. J.; Larsen,
P. R. Endocr. Rev. 2002, 23, 38–89. (b) K €o hrle, J. Methods Enzymol. 2002,
47, 125–167. (c) Kuiper, G. G. J. M.; Kester, M. H. A.; Peeters, R. P.;
Visser, T. J. Thyroid 2005, 15, 787–798.
3) (a) Visser, T. J.; Schoenmakers, C. H. H. Acta Med. Austriaca
(
3
(
1
992, 19, 18–21. (b) K €o hrle, J. Mol. Cell. Endocrinol. 1999, 151,
103–119.
(
(
4) Bianco, A. C.; Kim, B. W. J. Clin. Invest. 2006, 116, 2571–2579.
5) (a) Beck, C.; Jensen, S. B.; Reglinski, J. Bioorg. Med. Chem. Lett.
1
994, 4, 1353–1356. (b) Vasil’ev, A. A.; Engman, L. J. Org. Chem. 1998,
63, 3911–3917.
(
6) Goto, K.; Sonoda, D.; Shimada, K.; Sase, S.; Kawashima, T.
Angew. Chem., Int. Ed. 2010, 49, 545–547.
7) Manna, D.; Mugesh, G. Angew. Chem., Int. Ed. 2010, 49, 9246
249.
(
9
9
983
dx.doi.org/10.1021/ja201657s |J. Am. Chem. Soc. 2011, 133, 9980–9983